Structure-activity relationship of gambogic acid

Chinese Journal of Natural Medicines

Volumn 6, Issue 1, 2008, Pages 37-42

  Li, Nian Guang ^a,b,c   You, Qi Dong ^a,b   Huang, Xue Feng ^a,b   Wang, Jin Xin ^a,b   Guo, Qing Long ^a,b   Chen, Xiao Guang ^d   Li, Yan ^d   Li, Hong Yan ^d  

^a Key Laboratopry of Carcinogesis and Intervention of Jiangsu Province   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Antitumor activity; Gambogic acid; Small molecular compounds

Indexed keywords

1 (2,4,6 TRIHYDROXYPHENYL)ETHANONE; 1 HYDROXY 2,4 BIS(3 METHYLBUT 2 ENYL) 3 (3 METHYLBUT 2 ENYLOXY) 9H XANTHEN 9 ONE; 1 HYDROXY 9 OXO 9H XANTHEN 3 YLMORPHOLINE 4 CARBOXYLIC ACID; 1 HYDROXY 9 OXO 9H XANTHEN 3 YLPIPERIDINE 1 CARBOXYLIC ACID; 1,3 DIHYDROXY 2 (3 METHYLBUT 2 ENYL) 9H XANTHEN 9 ONE; 1,3 DIHYDROXY 2,4 BIS(3 METHYLBUT 2 ENYL) 9H XANTHEN 9 ONE; 1,3 DIHYDROXY 9H XANTHEN 9 ONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 5 ACETYL 8,8 DIMETHYL 8H PYRANO[3,2 G]CHROMONE; 5 HYDROXY 2,2 DIMETHYL 12 (3 METHYLBUT 2 ENYL)PYRANO[3,2 B]XANTHEN 6(2H) ONE; 5 HYDROXY 4 OXO 4H CHROMEN 7 YLMORPHOLINE 4 CARBOXYLIC ACID; 5 HYDROXY 4 OXO 4H CHROMEN 7 YLPIPERIDINE 1 CARBOXYLIC ACID; 5 HYDROXY 8,8 DIMETHYL 10 PRENYL 8H PYRANO[3,2 G]CHROMONE; 5 HYDROXY 8,8 DIMETHYL 8H PYRANO[3,2 G]CHROMONE; 5,7 DIHYDROXY 4,6 DIPRENYLCHROMONE; 5,7 DIHYDROXY 6 PRENYLCHROMONE; 5,7 DIHYDROXYCHROMONE; CHROMONE DERIVATIVE; GAMBOGIC ACID; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 39049122132     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/s1875-5364(09)60003-0     Document Type: Article

References (11)

1. Zhang HZ, Kasibhatla S, Wang Y, et al. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay [J]. Bioorg Med Chem, 2004, 12 (2): 309-317.
2. Kasibhatia S, Jessen KA, Maliartchouk S, et al. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid[J]. Proc Natl Acad Sci USA, 2005, 102(34): 12095-12100.
3. Zhao L, Guo QL, You QD, et al. Gambogic acid induces apoptosis and regulates expressions of bax and Bcl-2 protein in human gastric carcinoma MGC-803 Cells [J]. Biol Pharm Bull, 2004, 27(7): 998-1003.
4. Yu J, Guo QL, You QD, et al. Repression of telomerase teverse transcriptase mRNA and hTERT promoter by inhibitory effects of oncogene C-myc in gambogic acid treated-human gastric carcinoma cells [J]. Cancer Chemother Pharmacol, 2006, 58(6): 434-443.
5. Cochet C, Feige JJ, Pirollet F, et al. Selective inhibition of a cyclic nucleotide independent protein kinase (G type casein kinase) by quercetin and related polyphenols[J]. Biochem Pharmacol, 1982, 31(7): 1357-1361.
6. Gshwendt W, Horn F, Kittstein W, et al. Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin [J]. Biochem Biophys Res Commun, 1983, 117(2): 444-447.
7. Srivastava AK. Inhibition of phosphorylase kinase, and tyrosine protein kinase activities by quercetin[J]. Biochem Biophys Res Commun, 1985, 131(1): 1-5.
8. Fellows IM, Schwaebe M, Dexheimer TS, et al. Determination of the importance of the stereochemistry of psorospermin in topoisomerase II-induced alkylation of DNA and in vitro and in vivo biological activity[J]. Mol Cancer Ther, 2005, 4 (11): 1729-1739.
9. Ito C, Itoigawa M, Furukawa H, et al. Xanthones as inhibitors of Epstein-Barr virus activation[J]. Cancer Lett, 1998, 132(1-2): 113-117.
10. Jain AC, Gupta SM, Tyagi OD. Aromatic benzylation of 5,7-dihydroxyehromone & 5,7-dihydroxy-2-methylisoflavone [J]. Indian J Chem, 1984, 23B(11): 1036-1039.
11. Mosman T. Rapid colorimetric assay for cellular growth and cytotoxicity assays[J]. J Immunol Methods, 1983, 65(1): 55-63.